INCYTE CORP INCYTE ORD SHS (0J9P.L) Financials

0J9P.L Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 6.4 billion 1.5 billion
2023-06-30 6.2 billion 1.5 billion
2023-03-31 5.8 billion 1.3 billion

0J9P.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 136.9 million 48.0 million
2023-06-30 299.2 million 54.5 million
2023-03-31 -117.5 million 53.4 million

0J9P.L Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 201.1 million
2023-09-30 171.3 million
2023-06-30 203.5 million
2023-03-31 21.7 million

0J9P.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 3.5 billion - -
2023-06-30 3.4 billion - -
2023-03-31 3.1 billion - -

0J9P.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 ?
2023-09-30 226.2 million
2023-06-30 225.6 million
2023-03-31 225.6 million

0J9P.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 11.0 million 387.0 million - -
2023-06-30 7.3 million 425.9 million - -
2023-03-31 11.9 million 407.2 million - -

0J9P.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 919.0 million 436.9 million
2023-06-30 954.6 million 468.5 million
2023-03-31 808.7 million 462.1 million

0J9P.L

Price: $57.12

52 week price:
50.81
75.42

Earnings Per Share: 4.20 USD

P/E Ratio: 13.82

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 115.8 million

Links: